Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer

Author： Siemerink Ester   Drenth Annemieke   Mulder Nanno   Plukker John   Hospers Geke  

Publisher： Springer Publishing Company

ISSN： 1436-3291

Source： Gastric Cancer, Vol.13, Iss.2, 2010-06, pp. : 95-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer

By Idelevich Efraim   Karminsky Natalie   Dinerman Michael   Katsenelson Rivka L.   Zvi Nana Ben   Baruch Noa Ben   Biran Haim   Man Sofia   Shani Adi  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 324-329

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of UFT and leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer

By Gyldenkerne Niels   Glimelius Bengt   Frödin Jan Erik   Kjaer Mogens   Pfeiffer Per   Hansen Flemming   Keldsen Nina   Sandberg Erik   Jakobsen Anders  

Acta Oncologica, Vol. 43, Iss. 3, 2004-04 ,pp. : 276-279

Informa Healthcare

Access to resources Recommend Favorite

Phase II Study of Gemcitabine, UFT and Leucovorin in Patients with Advanced Pancreatic Cancer

By Kim Tae Won   Kang Hae Jin   Ahn Jin Hee   Lee Keehyun   Chang Heung Moon   Kang Yoon Koo   Lee Jung Shin  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 689-694

Informa Healthcare

Access to resources Recommend Favorite

Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study

By Catalano Vincenzo   Vincenzi Bruno   Giordani Paolo   Graziano Francesco   Santini Daniele   Baldelli Anna   Alessandroni Paolo   Schiavon Gaia   Rossi David   Casadei Virginia   D’Emidio Silvia   Luzi Fedeli Stefano   Tonini Giuseppe   Fiorentini Giammaria  

Gastric Cancer, Vol. 15, Iss. 4, 2012-10 ,pp. : 419-426

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer

By Oh Sung Yong   Kwon Hyuk-Chan   Seo Bong-Gun   Kim Sung-Hyun   Kim Jae-Seok   Kim Hyo-Jin  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 336-341

Informa Healthcare

Access to resources Recommend Favorite